1. Introduction {#sec1}
===============

Plant derived compounds play a key role in food science technologies. To identify new candidate compounds we will investigate plant sources that have established uses as homeopathic remedies. Vietnamese coriander (*Polygonum odoratum*) is a south-east Asian herb ([@bib18]) with homeopathic medicinal qualities ([@bib5]) including the treatment of stomach pains ([@bib4]), acting as an anti-inflammatory and has also been shown to have anti-bacterial activity ([@bib1]; [@bib2]; [@bib3]). Additionally, *P. ordoratum* plant extracts are known to have high levels of antioxidant compounds. The leaves of the perennial herb are pointed with distinctive purple bands in the center of the green leaves ([@bib20]). Interestingly, when exposed to air the leaf of *P. odoratum* does not brown, which typically occurs due to the formation of the polymer melanin ([@bib11]). This suggests that the compounds in *P. odoratum* may have the potential to prevent melanin production (melanogenesis). Identification of an effective melanogenesis inhibitor has important food science applications such as extending the shelf-life of fresh foods and reducing food waste ([@bib7]). The enzyme responsible for initiating melanin production is tyrosinase (EC 1.14.18.1), a type III copper containing oxidase ([@bib17]). The active site of tyrosinase contains two copper ions coordinated by histidine residues ([@bib14]). Tyrosinase catalyzes the first two reactions of the melanin formation pathway. In the first of these steps, the mono-phenol L-tyrosine is ortho-hydroxylated to form an ortho-diphenol, L-DOPA (L-3,4 dihydroxyphenylalanine). In the second step, tyrosinase oxidizes L-DOPA to dopaquinone ([@bib19]). Then, through a series of non-enzymatic reactions a stable intermediate, dopachrome is formed. Lastly, through oxidation and polymerization steps the pigment melanin is formed. Due to its central role in melanogenesis, tyrosinase inhibitors are expected to prevent melanin formation. In this work, we investigate the raw extract and the major compounds of *P. odoratum* essential oil as melanogenesis inhibitors. Gas chromatography-mass spectroscopy (GC-MS) of the extract revealed that 73% of the compounds present were aldehydes, with the three most prevalent compounds being dodecanal, decanal, and anisaldehyde. Previous works have identified anisaldehyde as a strong tyrosinase inhibitor ([@bib8]) however the major alkanals decanal and dodecanal to the best of our knowledge have not been reported as a tyrosinase or melanogenesis inhibitors. Our objective is to quantify the efficacy of these alkanal compounds as tyrosinase inhibitors. We hypothesize that the essential oil and major alkanals in the essential oil of *P. odoratum* will inhibit tyrosinase activity. The successful identification of a new natural product source with the ability to inhibit tyrosinase functionality would present opportunities in prevention of browning in food preservation.

2. Results {#sec2}
==========

2.1. Essential oil {#sec2.1}
------------------

Initial screening of the essential oil (EO) included both UV-Vis absorption, monitoring dopachrome formation, and oxygen consumption assays, following enzyme activity. The UV-Vis absorption and oxygen consumption assays revealed that 50 μg/mL EO inhibited the oxidation of L-DOPA (9% reduction in absorption relative to control) compared to vehicle treatment ([Fig. 1](#fig1){ref-type="fig"}a). Increasing the concentration of the essential oil to 100 μg/mL, and subsequently to 200 μg/mL, significantly suppressed both dopachrome formation and the oxygen consumption by 18 % and 35 %, respectively ([Fig. 1](#fig1){ref-type="fig"}a). Solubility issues above 200 μg/mL prevented testing at higher concentrations. A 10-minute pre-incubation of EO with tyrosinase significantly enhanced inhibitory efficacy for each concentration when measuring UV-Vis ([Fig. 1](#fig1){ref-type="fig"}a). In contrast, oxygen consumption assays performed after preincubation showed only an incremental increase in the inhibitory activity ([Fig. 1](#fig1){ref-type="fig"}b). The inhibitory activity of the essential oil suggests that one or more of the constituent compounds may be an effective inhibitor. The native substrate of tyrosinase, L-tyrosine, was also examined since the hydroxylation of the amino acid is the first step in the melanogenesis pathway. The essential oil showed poor inhibitory activity at 50 μg/mL. The presence of the essential oil at 100 μg/mL reduced enzyme activity by 15 % ([Fig. 2](#fig2){ref-type="fig"}). This level of inhibition was comparable to the L-DOPA results.Fig. 1UV-Vis absorption at 475 nm (**a**) and oxygen consumption (**b**) of 500 μM of L-DOPA with tyrosinase with essential oil (50 μg/mL, 100 μg/mL, 200 μg/mL).Fig. 1Fig. 2Oxygen consumption of the oxidation of 500 μM of L-tyrosine and essential oil at 100 μg/mL.Fig. 2

2.2. Major alkanals: dodecanal and decanal {#sec2.2}
------------------------------------------

The composition of the essential oil was determined using GC-MS with the list of identified compounds provided in [Table 1](#tbl1){ref-type="table"}. The three most prevalent compounds in the EO were identified as dodecanal (55.49 %, **1**), decanal (11.57 %, **2**) and anisaldehyde (6.35 %, **3**). Inhibition assays performed with an L-DOPA substrate at 250 μM dodecanal showed significant inhibition of enzyme activity in both UV-Vis and oxygen assays by 23% ([Fig. 3](#fig3){ref-type="fig"}a). At higher concentrations of 500 μM and 1000 μM there was a further significant reduction in dopachrome formation (UV-Vis absorption) by 30% and 57% respectively and oxygen consumption by 36% and 43% ([Fig. 3](#fig3){ref-type="fig"}b). A pre-incubation period of 10 min increased the inhibitory activity of dodecanal compared to the inhibition assays.Table 1GC-MS determined composition of essential oil from *P.odoratum*.Table 1RTCompounds% content30.16Dodecanal55.4919.39*n*-Decanal11.5765.8Pentacosane7.2618.29*p*-Anis aldehyde6.3533.58*n*-Dodecanol3.363.232*E*-Dodecenal2.531.94*α*-Humulene2.4139.42Humulene epoxide II1.5124.85Undecanal1.3123.26*n*-Decanol1.1338.17allo-Aromadendrene epoxide1.0865.452*E*-Tridecenal1.0737.73Methyl vanillin0.8640.58Zierone0.628.53*n*-Undecanol0.5659.53neoiso-Menthol0.4543.14-methylhexyl-2-methylbutyrate0.4342.53*β*-Bisabolol0.4146.25Drimenol0.3939.93Tetradecanal0.3464.19Triacontane0.3335.13*β*-Panasinsene0.3313.66*n*-Decane0.2611.483-Methyl-4-heptanone0.0552.14Polygodial0.01Fig. 3UV-Vis absorption at 475 nm (**a**) oxygen consumption (**b**) of 500 μM of L-DOPA with tyrosinase dodecanal at 250 μM, 500 μM, 1 mM.Fig. 3

However, for the 250 μM assay, the activity recovered to become comparable to the non-incubated samples over the measurement period of 30 min. An additional 10-minute incubation (20 min total) further improved dodecanal activity ([Fig. 3](#fig3){ref-type="fig"}a). The inhibitory activity of dodecanal (500 μM) on the native L-tyrosine substrate showed suppression of activity by 8% ([Fig. 4](#fig4){ref-type="fig"}).Fig. 4Oxygen consumption of the oxidation of 500 μM of L-tyrosine and dodecanal at 500 μM.Fig. 4

Decanal was the second most abundant compound (11.56%; 74.17 μM, **2**) in the essential oil. At concentrations of 125 μM there was no notable suppression of dopachrome formation, while at 250 μM and 500 μM there was significant suppression by 24% and 28%, respectively ([Fig. 5](#fig5){ref-type="fig"}). A pre-incubation period of 10 min significantly increased the inhibitory activity to 10%, 34% and 63% when measuring dopachrome formation at the same concentration. While oxygen consumption decreased by 11%, 33% and 36% at decanal concentrations of 250 μM, 500 μΜ and 1 mM, respectively. Interestingly, despite the significant improvement observed in the UV-Vis measurements, there was little effect of pre-incubation on oxygen consumption, with a difference of less than 9%. The only significant difference between the decanal and dodecanal is the side-chain length, suggesting the tail length plays a crucial role in determining the inhibitory activity.Fig. 5UV-Vis absorption at 475 nm (**a**) oxygen consumption (**b**) of 500 μM of L-DOPA with tyrosinase decanal at 125 μM, 250 μM, 500 μM or 1 mM.Fig. 5

The inhibitory activity of decanal was investigated using L-tyrosine as an alternative substrate. At 500 μΜ decanal suppressed enzyme activity by 11% when measuring oxygen consumption. The lag phase observed in L-tyrosine assays was not extended or curtailed ([Fig. 6](#fig6){ref-type="fig"}). The binding activity of dodecanal and decanal at the enzyme active site was investigated using fluorescence spectroscopy. We used the compound *N*-Phenyl-1-naphthylamine (1-NPN) since it strongly fluoresces in hydrophobic environments (Yin & others 2015). The active site in tyrosinase is hydrophobic but there are other hydrophobic regions within the tetramer subunits ([@bib10]). In the presence of L-DOPA, tyrosinase reconfigures to expose the hydrophobic active site, which can then be occupied by either L-DOPA or 1-NPN. The control measurements show an increase in fluorescence signal, consistent with 1-NPN being present at the active site. Once the alkanals are introduced, the fluorescence signal decreases continuously with time, suggesting the hydrophobic active site is now occupied by the inhibitors. At a concentration of 500 μΜ there was a significant decrease in fluorescence of 80% for dodecanal and 50% for decanal relative to L-DOPA ([Fig. 7](#fig7){ref-type="fig"}). Similar trends and quantitatively similar suppression of the fluorescence signal suggests that, despite their difference in inhibitory efficacy, dodecanal and decanal share a common presence in the hydrophobic regions of the enzyme.Fig. 6Oxygen consumption of the oxidation of 500 μM of L-tyrosine and decanal at 500 μM.Fig. 6Fig. 7Percentage fluorescence in the presence of tyrosinase and dodecanal and decanal. Asterisk indicate statistical significance (P \< 0.05).Fig. 7

Dodecanal and decanal were both effective tyrosinase inhibitors. The third major compound investigated was anisaldehyde, present at 46.69 μM (6.35%, **3**), which has previously been reported as a strong tyrosinase inhibitor ([@bib13]). In our testing, pre-incubation assays at 500 μM reduced enzyme activity by a significant 79% (data not shown). The common aldehyde head group shared by all the major compounds likely enables the inhibitory activity, while the tail group plays a role in determining the inhibitory efficacy. UV-Vis and oxygen consumption assays suggest the inhibitory binding may be irreversible.

2.3. Shaking effects and structural analogues {#sec2.3}
---------------------------------------------

Shaking experiments were performed to investigate reversibility of the inhibitor. It is expected that, for a reversible inhibitor, agitation (shaking) will re-disperse the compounds into solution, dissociating the inhibitor from the enzyme and consequently increasing activity. A dopachrome formation assay (monitored through UV-Vis) with excess L-DOPA was initiated and at 15 min the solution was removed, quickly agitated through vortexing, and returned to the spectrophotometer. This procedure can disrupt hydrophobic interactions, and introduces oxygen to the solution, promoting further substrate oxidation if the enzyme is still active. Thus, for a reversible inhibitor with weak binding there should be an increase in enzyme activity immediately following the agitation while an irreversible inhibitor would show a much smaller increase. When measuring dopachrome formation at 475 nm the vehicle (L-DOPA) increased 0.11 absorbance units, presumably due to newly introduced oxygen, establishing a baseline recovery from the disruption. This same shaking experiment with the essential oil and dodecanal showed an increase in 0.10 absorbance units and 0.05 absorbance units after shaking. The recovery of the essential oil was much larger than the increase from only the introduction of oxygen, indicating that the inhibitory activity is largely reversible, while the comparatively small recovery with the dodecanal indicates irreversibility. To investigate the role of side-chain length hexanal (C6) was also tested and showed an increase in 0.10 absorbance units, which was much more than dodecanal. This indicates a positive correlation between side-chain length and inhibitory activity.

To understand the role of the alkanal side-chain, shorter chain aliphatic aldehydes down to hexanal (**7**) were investigated. Longer chain aliphatic aldehydes are uncommon as natural products, so they were not examined. The saturated alkanals (**4-7**) ([Fig. 8](#fig8){ref-type="fig"}) were inhibitors of the tyrosinase catalyzed oxidation of L-DOPA. In general, pre-incubation increased alkanal activity on L-DOPA ([Table 1](#tbl1){ref-type="table"}). After 10 min of pre-incubation, compounds shorter than decanal (C10) had a lower magnitude of increasing tyrosinase inhibitory activity, suggesting that the chain length may play a role in the pre-incubation effect. Consistent with the earlier dodecanal and decanal treatments, assays performed on an L-tyrosine substrate showed weaker inhibition activity compared to those on L-DOPA. Additionally, pre-incubation with L-tyrosine ([Table 2](#tbl2){ref-type="table"}) did not improve inhibitory activity. Fluorescence measurements with 1-NPN support that these compounds significantly interact at hydrophobic sites and suggests that the alkanal side-chain length affected the activity of the enzyme.Fig. 8Structure of dodecanal (1), decanal (2), anisaldehyde (3), nonanal (4), octanal (5), heptanal (6), hexanal (7).Fig. 8Table 2**Alkanal inhibitory activity** UV-Vis absorption at 475 nm of 500 μM of L-DOPA with tyrosinase and various alkanals at 500 μM and percentage fluorescence of alkanals on L-DOPA. Asterisk indicates values of P \< 0.05 were considered statistically significant (\*).Table 2Compound% Change of enzyme inhibition Pre-incubated% FluorescenceC6289C7380C8575C9825C1036\*50C1232\*20

3. Discussion {#sec3}
=============

The spectroscopy and oxygen consumption assays confirm our hypothesis that Vietnamese coriander essential oil and its major components (dodecanal, decanal, and anisaldehyde) effectively inhibit the tyrosinase catalyzed oxidation of L-DOPA. All of the major compounds have an aldehyde head group, suggesting this may be the source of the observed inhibitory activity, while the inhibitory efficacy is determined by the side chain group. The role of the side-chain group is further emphasized by comparing the inhibitory efficacy of dodecanal, decanal and hexanal. Shaking experiments support the irreversible inhibitory activity of dodecanal efficacy.

In a possible inhibitory mechanism, the aldehyde head group quickly binds at hydrophobic sites on the enzyme, and then the aliphatic tail group disrupts the enzyme tertiary structure through hydrophobic interactions. The tyrosinase active site in particular has been previously suggested to be susceptible to inhibitory molecules, following binding by a Schiff base formation, a non-competitive mechanism ([@bib12]). Specifically, the double-bound oxygen located on the aldehyde head undergoes a single-replacement with a nitrogen in the active pocket and forms a Schiff base with a primary amino group ([@bib23]). In these previous cases the inhibitor was an alpha, beta aldehyde which is known to be more reactive than the unsaturated counterparts explored here. The Schiff base mechanism is expected to be reversible ([@bib21]) and does not consume additional oxygen from the solution, consistent with the oxygen consumption assays. Pre-incubation assays improved inhibitory activity without significantly increasing the amount of oxygen consumed. This is consistent with the above explanation but also suggests a time-dependent inhibition in which the hydrophobic side-chain requires time to bind with the enzyme and disrupt the tertiary structure. The hydrophobic portions of the enzyme include the active pocket but additionally are responsible for stabilizing the subunits of the tyrosinase tetramer ([@bib10]). Native proteins, including tyrosinase, are known to have poor conformational stability and are sensitive to hydrophobic disruptions ([@bib6]). The aldehyde head group found on the major compounds is hydrophilic, with a hydrophobic aliphatic tail, with the longer chains being more hydrophobic. At low concentrations the polar head keeps the compound dissolved as a monomer ([@bib16]). Once the concentration of the compound is increased the monomers start to associate through their hydrophobic tails to form micelles ([@bib15]). Thus, the reduction of dopachrome formation by the essential oil could also have been due to the interference as a surfactant-like inhibitor ([@bib15]). Here, we suggest an inhibitory mechanism in which the aldehyde head moiety (I) acts as a 'barb' reversibly and quickly binding to the enzyme (E) active pocket and forming an EI complex as a non-competitive inhibitor. Then slow hydrophobic interactions between the alkyl chain and the hydrophobic domain of the enzyme disrupt the enzymes\' tertiary structure, reducing activity.

These results present new opportunities for effective tyrosinase inhibitors. Since the essential oil is derived from a plant source ([@bib9]) this could be a sustainable alternative to synthetic topical anti-browning control agents. The principle compounds investigated in this work currently have commercial uses, and this work demonstrates and expanded potential for these compounds as tyrosinase inhibitors.

4. Experimental {#sec4}
===============

4.1. Materials {#sec4.1}
--------------

L-DOPA (CAS \# 59-92-7), L-tyrosine (CAS \# 60-18-4), dodecanal (CAS \# 112-54-9), decanal (CAS \# 112-31-2), and all other alkanals and dimethyl sulfoxide (DSMO) (CAS \# 67-68-5) were purchased from Sigma-Aldrich (Milwaukee, MN, USA). Mushroom derived tyrosinase (CAS \# 9002-10-2) was also purchased from Sigma-Aldrich and was further purified by anion-exchange chromatography using DEAE-Sepharose Fast Flow (Pharmacia, Uppsala, Sweden), as previously described ([@bib19]). All measurements were made in triplicate and on separate occasions.

4.2. Collection and extraction {#sec4.2}
------------------------------

Fresh leaves of *P. ordoratum* were collected in the Nakhon Phatom province, Thailand in 2013. The fresh leaf material was steam distilled and essential oil collected and extracted as described in [@bib5]. The essential oil was then stored at -30 °C for further analysis.

4.3. GC-MS analysis {#sec4.3}
-------------------

The essential oil of *P. odoratum* was analyzed through gas chromatography-mass spectroscopy from [@bib5], using a GC-17A/QP5050 (Shimadzu Co., Ltd., Kyoto, Japan) with a DB-5 column (0.25 mm × 30 mm i.d. with 0.25 μm film thickness) (J & W Scientific Inc., Folsom, USA). The temperature pattern was as described: 45 °C for 8 min, followed by an increase of 2.5 °C min^−1^ to 180 °C, and 10 °C min^−1^ to 250 °C, and held there for 3 min. Additional testing settings were: an injection temperature of 250 °C, an ion source temperature of 250 °C, ionization energy of 70 eV, the carrier gas was He at 1.7 mL min^−1^, an injection volume of 1 μL (90 μg/mL Et~2~O), split ratio 1:20, and mass range m/z 50 to 450. Identification of the compounds was performed by comparison of the mass spectrum with the mass spectra database Wiley 9^th^ library and NIST08 library.

4.4. In-vitro enzyme assay {#sec4.4}
--------------------------

### 4.4.1. Spectroscopy {#sec4.4.1}

Photo-spectroscopy (UV-VIS) measurements were performed at 475 nm on a Shimadzu 1700 (Tokyo, Japan). This wavelength allows the identification of dopachrome. Samples were dissolved in DMSO and the final concentration of DMSO was always 3%. Inhibition assays were performed by dissolving samples in DMSO and only used for experimentation after their dilution. The final concentration of DMSO was always 3%. For inhibition assays, a test solution of 3 ml was prepared consisting of 1.95 ml distilled and filtered H~2~0, 0.725 ml of 67 mM phosphate buffer (pH = 6.8), 0.125 ml L-DOPA (from a 6 mM stock) were mixed and incubated at 30 °C for 5 min. At this point, the 100 μl of the sample solution and 100 μl of the purified tyrosinase in phosphate buffer was added (1 μg/ml) to the mixture in this order. Once tyrosinase was added to the solution the absorbance was measured for 30-60 min. For pre-incubation assays 1.95 ml distilled and filtered H~2~0, 0.725 ml of 67mM phosphate buffer (pH = 6.8), 100 μl of the sample solution and 100 μl of the purified tyrosinase was added (1 μg/ml) and incubated for 10 min (or 20 min) at 30 °C, prior to the addition of L-DOPA. For assays testing an L-tyrosine substrate the same procedures were followed. This methodology was adapted from previously reported method ([@bib19]), with a final concentration of enzyme at 1 μg/mL and kojic acid as the positive control.

### 4.4.2. Oxygen consumption {#sec4.4.2}

Oxygen consumption measurements were taken using an OBH 100 oxygen electrode with a water jacket chamber using an YSI 5300 oxygen monitor (all from Yellow Springs Instruments Co., Yellow Springs, OH). Inhibition and pre-incubation assays were preformed as described above, oxygen consumption was then monitored at 30 °C for 30 min.

### 4.4.3. Fluorescence {#sec4.4.3}

Fluorescence measurements of inhibitory activity were performed using *N*-Phenyl-1-naphthylamine (1-NPN). We followed procedures from ([@bib22]) with slight modification. Measurements were performed on an EnVision Plate reader 2104i (Perkin-Elmer, Waltham, MA,USA), using a 340 nm excitation light and monitoring emissions at 460 nm. Inhibitory assay solutions were prepared as described above, with the fluorescence probe 1-NPN(20 μM) added to the solution, then the solution was incubated at 30 °C for 10 min. The 1-NPN mixtures were loaded into the wells of a 96 well plate, then the candidate inhibitor was added to this solution followed by the tyrosinase. Emissions were measured every 5 min for 30 min total. To avoid light interference, measurements were taken only after the light path way was shut for at least 10 s.

### 4.4.4. Statistical analysis {#sec4.4.4}

Data is presented as the mean and standard error mean (mean ± SEM). The data analysis was performed using a one-way-analysis of variance (ANOVA) followed by a post hoc Tukey test using R version 3.1.3. Statistical differences less than P \< 0.05 were considered statistically significant.

Declarations {#sec5}
============

Author contribution statement {#sec5.1}
-----------------------------

Anne F. Murray: Performed the experiments; Analyzed and interpreted the data; Wrote the paper.

Hiroki Satooka: Performed the experiments.

Kuniyoshi Shimizu, Warinthorn Chavasiri: Contributed reagents, materials, analysis tools or data.

Isao Kubo: Conceived and designed the experiments.

Funding statement {#sec5.2}
-----------------

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Competing interest statement {#sec5.3}
----------------------------

The authors declare no conflict of interest.

Additional information {#sec5.4}
----------------------

No additional information is available for this paper.
